NewsWhore
12-18-2007, 04:30 PM
LONDON (Reuters) - AstraZeneca Plc's experimental cancer drug AZD2281 has been given orphan drug status by the European Medicines Agency for treating women with ovarian cancer, Britain's second bigges...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/11728491/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/11728491/)